Zogenix Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

Zogenix Inc.

announced today that it intends to offer units in an underwritten public offering, with each unit consisting of one share of Zogenix's common stock and a warrant to purchase a certain number of shares of Zogenix's common stock. All of the units are being offered by Zogenix. Zogenix intends to use the net proceeds from the offering to repay all amounts outstanding under its amended and restated loan and security agreement with Oxford Finance LLC and Silicon Valley Bank, to fund the pre-approval and pre-commercialization activities of Zohydro™ ER, for the ongoing commercialization of Sumavel® DosePro® and for working capital and other general corporate purposes.